Hosted on MSN27d
Teva Pharmaceutical Industries (TEVA) Reports Q4 Earnings: What Key Metrics Have to Say
Teva Pharmaceutical Industries Ltd. (TEVA) reported $4.23 billion in revenue for the quarter ended December 2024, representing a year-over-year decline of 5.1%. EPS of $0.71 for the same period ...
Reuters27d
Teva Pharm tops quarterly estimates but 2025 earnings outlook falls short
JERUSALEM, Jan 29 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA ... For all of 2024, Teva recorded diluted EPS of $2.49 ex-items - above estimates of $2.47 - compared with $2.56 in 2023.